Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
Income from Continuing Operations
Jiangsu Bioperfectus Technologies Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
Income from Continuing Operations
-¥373.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Income from Continuing Operations
¥2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Income from Continuing Operations
¥830.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Income from Continuing Operations
¥1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Income from Continuing Operations
¥628.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Bioperfectus Technologies Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-373.8m
CNY
Based on the financial report for Dec 31, 2023, Jiangsu Bioperfectus Technologies Co Ltd's Income from Continuing Operations amounts to -373.8m CNY.